Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2018
Reporting Period: Second Quarter of 2018
This filing serves as a notification that the Company issued a press release on August 8, 2018, announcing its financial results for the second quarter of 2018. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing explicitly states that the detailed results are contained in the attached press release (Exhibit 99.1), which is not included in the input text.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only references the announcement of Q2 2018 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q2 2018 results but does not include the content of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any other filing unless expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 8, 2018) for actual Q2 2018 revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any forward-looking statements or guidance updates within the press release.
- Confirm the status of the Company's emerging growth company election (indicated as not elected in the filing).